109 related articles for article (PubMed ID: 33714676)
21. CCND1-Induced Autophagy Contributes to Lymph Node Metastasis in Endometrial Cancer.
Su Y; Zhou H; Ma Z; Liu J; Li C
Horm Metab Res; 2023 Jun; 55(6):413-419. PubMed ID: 37019147
[TBL] [Abstract][Full Text] [Related]
22. Circ-UBR1 facilitates proliferation, metastasis, and inhibits apoptosis in breast cancer by regulating the miR-1299/CCND1 axis.
Zhang L; Sun D; Zhang J; Tian Y
Life Sci; 2021 Feb; 266():118829. PubMed ID: 33259864
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-383 inhibits anchorage-independent growth and induces cell cycle arrest of glioma cells by targeting CCND1.
Xu Z; Zeng X; Tian D; Xu H; Cai Q; Wang J; Chen Q
Biochem Biophys Res Commun; 2014 Oct; 453(4):833-8. PubMed ID: 25450356
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1.
Han K; Chen X; Bian N; Ma B; Yang T; Cai C; Fan Q; Zhou Y; Zhao TB
Oncotarget; 2015 Apr; 6(11):8875-89. PubMed ID: 25823925
[TBL] [Abstract][Full Text] [Related]
25. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
[TBL] [Abstract][Full Text] [Related]
26. Role of MicroRNA-93 I in Pathogenesis of Left Ventricular Remodeling via Targeting Cyclin-D1.
Zhang J; Qin L; Han L; Zhao Y; Jing H; Song W; Shi H
Med Sci Monit; 2017 Aug; 23():3981-3988. PubMed ID: 28817550
[TBL] [Abstract][Full Text] [Related]
27. circRNA circ-CCND1 promotes the proliferation of laryngeal squamous cell carcinoma through elevating CCND1 expression via interacting with HuR and miR-646.
Zang Y; Li J; Wan B; Tai Y
J Cell Mol Med; 2020 Feb; 24(4):2423-2433. PubMed ID: 31951319
[TBL] [Abstract][Full Text] [Related]
28. Elevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patients.
Xu P; Zhao M; Liu Z; Liu Y; Chen Y; Luo R; Fang W
Int J Clin Exp Pathol; 2015; 8(12):15887-94. PubMed ID: 26884860
[TBL] [Abstract][Full Text] [Related]
29. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma.
Dionysopoulos D; Pavlakis K; Kotoula V; Fountzilas E; Markou K; Karasmanis I; Angouridakis N; Nikolaou A; Kalogeras KT; Fountzilas G
Strahlenther Onkol; 2013 Mar; 189(3):202-14. PubMed ID: 23400686
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
Zhu Y; Wen X; Zhao P
Med Sci Monit; 2018 Jun; 24():3679-3692. PubMed ID: 29858490
[TBL] [Abstract][Full Text] [Related]
32. E2F transcription factor 1 elevates cyclin D1 expression by suppressing transcription of microRNA-107 to augment progression of glioma.
Xie H; Lv S; Wang Z; Yuan X
Brain Behav; 2021 Dec; 11(12):e2399. PubMed ID: 34758200
[TBL] [Abstract][Full Text] [Related]
33. Role of microRNA-4458 in patients with non-small-cell lung cancer.
Bao L; Wang L; Wei G; Wang Y; Wuyun G; Bo A
Oncol Lett; 2016 Nov; 12(5):3958-3966. PubMed ID: 27895756
[TBL] [Abstract][Full Text] [Related]
34. LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer.
Wang L; Tang L; Ge T; Zhu F; Liu D; Guo H; Qian P; Xu N
BMC Pulm Med; 2021 Aug; 21(1):277. PubMed ID: 34454450
[TBL] [Abstract][Full Text] [Related]
35. Cyclin D1 overexpression in Algerian breast cancer women: correlation with CCND1 amplification and clinicopathological parameters.
Mohammedi L; Doula FD; Mesli F; Senhadji R
Afr Health Sci; 2019 Jun; 19(2):2140-2146. PubMed ID: 31656498
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.
Duan G; Zhang C; Xu C; Xu C; Zhang L; Zhang Y
Int J Oncol; 2019 Jan; 54(1):17-28. PubMed ID: 30365098
[TBL] [Abstract][Full Text] [Related]
37. MiR-3663-3p Inhibits the Progression of Gastric Cancer Through the CCND1 Pathway.
Takao K; Konishi H; Matsubara D; Shoda K; Arita T; Shimizu H; Komatsu S; Shiozaki A; Yamamoto Y; Kubota T; Fujiwara H; Okamoto K; Otsuji E
Anticancer Res; 2021 May; 41(5):2441-2449. PubMed ID: 33952469
[TBL] [Abstract][Full Text] [Related]
38. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis.
Yan F; Ma Y; Liu L; Li L; Deng J; Sun J
J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404
[TBL] [Abstract][Full Text] [Related]
39. High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer.
Roy PG; Pratt N; Purdie CA; Baker L; Ashfield A; Quinlan P; Thompson AM
Int J Cancer; 2010 Jul; 127(2):355-60. PubMed ID: 19904758
[TBL] [Abstract][Full Text] [Related]
40. MiRNA-30 Play an Important Role in Non-Small Cell Lung Cancer (NSCLC).
Sui JYAX
Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
